Ticker Launch
Sign inTry it free

IPO · HKPD

Cellyan Biotechnology Co., Ltd

Formerly Hong Kong Pharma Digital Technology Holdings Ltd

Cellyan Biotechnology Co., Ltd (HKPD) priced its initial public offering on Jan 15, 2025 at $4.00 per share, raising $5.6M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $44M. Bevilacqua, Harneys, DeHeng Law Offices and Beijing Deheng Law Offices advised the company and Ortoli Rosenstadt advised the underwriters.

Status
IPO
Ticker
HKPD
Exchange
Nasdaq Capital Market
Priced
Jan 15, 2025
IPO price
$4.00
Raised
$5.6M
Market cap at IPO price
$44M
First filed
Oct 29, 2024
Company counsel
Bevilacqua, Harneys, DeHeng Law Offices and Beijing Deheng Law Offices
Underwriters' counsel
Ortoli Rosenstadt
Sector
Healthcare

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.

More on this listing for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other Healthcare IPOs in 2025